New Formulation for the Delivery of Oligonucleotides Using “Clickable” siRNA-Polyisoprenoid-Conjugated Nanoparticles: Application to Cancers Harboring Fusion Oncogenes-Reference-Cited by-同舟云学术

New Formulation for the Delivery of Oligonucleotides Using “Clickable” siRNA-Polyisoprenoid-Conjugated Nanoparticles: Application to Cancers Harboring Fusion Oncogenes

Published:2018-05-04 Issue:6 Volume:29 Page:1961-1972
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Massaad-Massade Liliane¹²³^ORCID,Boutary Suzan¹²³,Caillaud Marie¹²³,Gracia Celine¹²³,Parola Beatrice⁴,Gnaouiya Soukaina Bel⁴,Stella Barbara⁴^ORCID,Arpicco Silvia⁴,Buchy Eric⁵,Desmaële Didier⁵,Couvreur Patrick⁵,Urbinati Giorgia¹²³

Affiliation:

1. Université Paris-Saclay, Laboratoire de Vectorologie et Thérapeutiques Anticancéreuses, UMR 8203, Villejuif, France-94805

2. CNRS, Laboratoire de Vectorologie et Thérapeutiques Anticancéreuses, UMR 8203, Villejuif, France-94805

3. Gustave Roussy, Laboratoire de Vectorologie et Thérapeutiques Anticancéreuses, UMR 8203, Villejuif, France-94805

4. Università degli Studi di Torino, Dipartimento di Scienza e Tecnologia del Farmaco, Via Pietro Giuria 9, 10125 Torino, Italy

5. Institut Galien, UMR CNRS 8612, Université Paris-Saclay, Faculté de Pharmacie, 5 rue J. B. Clément, 92296 Châtenay-Malabry, France

Funder

Agence Nationale de la Recherche

Centre National de la Recherche Scientifique

Comit? du Val-de-Marne, Ligue Contre le Cancer

Comit? des Yvelines, Ligue Contre le Cancer

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.8b00205

Reference32 articles.

1. Safety of antisense oligonucleotide and siRNA-based therapeutics

2. FDA-Approved Oligonucleotide Therapies in 2017

3. Knocking down barriers: advances in siRNA delivery

4. RNA Interference (RNAi)-Based Therapeutics: Delivering on the Promise?

5. Current progress of siRNA/shRNA therapeutics in clinical trials

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid nanoparticles for RNA delivery: Self-assembling vs driven-assembling strategies;Advanced Drug Delivery Reviews;2024-05

2. Clicking in harmony: exploring the bio-orthogonal overlap in click chemistry;RSC Advances;2024

3. RNA Combined with Nanoformulation to Advance Therapeutic Technologies;Pharmaceuticals;2023-11-21

4. Self-assembled lipid–prodrug nanoparticles;Nature Reviews Bioengineering;2023-06-28

5. Development and Characterization of Innovative Multidrug Nanoformulation for Cardiac Therapy;Materials;2023-02-22